RE:RE:Boy am I glad I was out! but at $11 and change???Sorry, I'm a contrarian investor. I know I should probably short and retail investment platforms now have views into your short positions but that's even more ammunition by the street (most of you 24x7 guys) against the little part time investor. The average guys can't beat the street, it's like trying to win against the House.
Shorting is the cancer of the investment community. That and financial derivatives are all Wall Street instruments to screw up true investing. Look at the attrocities of financial meltdown of 2008/2009 for proof. Looks like we'll need another disaster for the regulators and governments to wake up.
Until then, we'll have institutional and "big money" "pump and dumps" because they make money both ways on the back of the average investor.
CNInvesting wrote: Yes there's something a lot better for a contrarian...short the S&P500. It's gonna crash sooner or later. Markets are disconnected from the underlying economy sucks and debt to gdp is at an all-time high. Right now S&P is trading at a 20x p/e. I think it should be trading at max 16x. You're right that there's a reasonnable margin of safety with CXR right now, but not without risk and considering what's been going on lately, I wouldn't get back in. There are some serious issues here that need to be adressed, something the management seems unable to do so far.
FullReversal wrote:
I've been buying and selling this this over longer cycles and doing well. At below $12.... the other shoe can fall here with banksters' downgrades or take over suitors can be tripping over each other for a chance to take this on.
Problem is, if they want to take it private, they can continue to pound away at it at shareholder's expense. I actually hate the sector, drug price gouging isn't what makes me a proud member of the true investor community. Brand names are under assault from the generics and that's supported by the politicians and public.
That and the Amdipharm Mercury acquisition stinks to high heaven, that's the biggest obstacle I see to me putting my money back on this horse! But from a pure financial perspective, sub $12 looks mighty good.... Anyone have any better picks for the contrarians?
Or maybe I'll just wait this out a bit more.... Let's see if there is any intelligence responses... Something very, very hard to get from Stockhouse...